Success Metrics

Clinical Success Rate
100.0%

Based on 32 completed trials

Completion Rate
100%(32/32)
Active Trials
4(11%)
Results Posted
19%(6 trials)

Phase Distribution

Ph not_applicable
1
3%
Ph phase_2
4
11%
Ph phase_1
25
69%
Ph phase_4
1
3%
Ph phase_3
3
8%

Phase Distribution

25

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution34 total trials
Phase 1Safety & dosage
25(73.5%)
Phase 2Efficacy & side effects
4(11.8%)
Phase 3Large-scale testing
3(8.8%)
Phase 4Post-market surveillance
1(2.9%)
N/ANon-phased studies
1(2.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

32 of 32 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

36

all time

Status Distribution
Active(4)
Completed(32)

Detailed Status

Completed32
Active, not recruiting3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 125 (73.5%)
Phase 24 (11.8%)
Phase 33 (8.8%)
Phase 41 (2.9%)
N/A1 (2.9%)

Trials by Status

active_not_recruiting38%
completed3289%
recruiting13%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT03964090Phase 2

Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)

Active Not Recruiting
NCT02203526Phase 1

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

Active Not Recruiting
NCT04550936

A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions.

Completed
NCT07191756

Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study

Active Not Recruiting
NCT05630976Phase 4

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Completed
NCT03149055Phase 2

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Completed
NCT06440915Not Applicable

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children

Recruiting
NCT00634049Phase 3

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Completed
NCT00413218Phase 3

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

Completed
NCT00412893Phase 3

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Completed
NCT00413439Phase 2

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Completed
NCT05140096Phase 1

A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult Participants

Completed
NCT03019939Phase 2

Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia

Completed
NCT01657890Phase 1

Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects

Completed
NCT01582412Phase 1

Drug Interaction Study of Isavuconazole and Digoxin

Completed
NCT01657838Phase 1

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects

Completed
NCT01635972Phase 1

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Completed
NCT01555866Phase 1

Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.

Completed
NCT01651325Phase 1

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects

Completed
NCT01635946Phase 1

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin

Completed

Drug Details

Intervention Type
DRUG
Total Trials
36